Meningitis B Outbreak in Kent: Cases Decline as Vaccination Efforts Continue

The number of confirmed cases of invasive meningococcal disease (MenB) linked to an outbreak in Kent, UK, has decreased as vaccination and antibiotic treatment programs continue, according to the latest update from the UK Health Security Agency (UKHSA). While the situation remains serious, the decline in cases offers a measure of reassurance as health officials work to contain the outbreak.

Current Status of the Outbreak

As of March 22, 2026, the UKHSA reports 20 laboratory-confirmed cases of invasive meningococcal disease, a decrease from 23 reported previously. Nine cases remain under investigation, bringing the total number of notified cases to 29, down from 34 yesterday. Some cases initially classified as confirmed have been reclassified following further laboratory analysis and clinical investigation UKHSA.

Nineteen of the 20 confirmed cases are attributed to the MenB strain. All confirmed cases have required hospital admission. Sadly, two people have died as a result of the outbreak: 18-year-old Juliette Kenny and a student at the University of Kent The Independent.

Vaccination and Antibiotic Distribution

Health officials are prioritizing preventative measures to curb the spread of the disease. More than 8,000 meningitis B vaccines and 12,157 doses of preventative antibiotics have been distributed as of Saturday evening Cambridge News.

Preventative antibiotics are currently being offered to:

• Close contacts of confirmed or suspected cases.
• Students at the University of Kent’s Canterbury Campus, including those who have returned home.
• Some staff living or working in University of Kent halls of residence.

Eligible University of Kent students who have returned home can access both the MenB vaccination and preventative antibiotic treatment from their local General Practitioner (GP). Students returning to Scotland should contact their local NHS Board’s Health Protection Team (HPT) UKHSA Blog.

Understanding Meningococcal Disease and MenB

Meningococcal disease is a serious, though uncommon, illness caused by meningococcal bacteria. It can lead to meningitis (inflammation of the brain’s lining) and sepsis. The current outbreak in Kent is specifically linked to the MenB strain UKHSA Blog.

MenB is spread through close and prolonged contact, such as living in the same household or through intimate contact like kissing or sharing items like drinks or vapes. The bacteria are not as contagious as viruses like measles or COVID-19 UKHSA Blog.

Symptoms and Advice

The UKHSA emphasizes the importance of recognizing the symptoms of invasive meningococcal disease and seeking immediate medical attention if they develop. While the risk to the wider population remains low, vigilance is crucial.

Dr. Sherine Thomas, Infectious Diseases Consultant at UKHSA, stated, “We continue to remain vigilant for new cases and work closely with NHS England and local authorities across the country to ensure that any new cases identified are responded to as quickly as possible.” UKHSA

Looking Ahead

The UKHSA expects further cases to be downgraded as more laboratory assessments are completed. Health officials will continue to monitor the situation closely and provide updates as they become available. The focus remains on identifying contacts, offering treatment, and encouraging eligible individuals to receive the vaccine, and antibiotics.